Stocks To Buy Now Blog

Stocks on Radar

The Safe-Haven Asset Crypto Investors Are Missing

In recent years, cryptocurrency has captured the imagination of investors, who have embraced it as a revolutionary asset class offering high-growth potential. With Bitcoin and other digital currencies reaching new heights, many investors have turned to the crypto market as their hedge against inflation, government intervention and traditional assets. But there’s a time-tested asset that deserves more attention and has also been reaching all-time highs this year: gold.

Much like Bitcoin, gold’s scarcity is one of the key factors driving its value. The finite nature of both assets appeals to investors who are drawn to the idea of owning something limited in supply. Gold has long been a store of value, offering a hedge against the devaluation of fiat currencies. Its remarkable ability to retain value over time has made it an essential part of portfolios during periods of economic instability.

While Bitcoin has only been around for a little over a decade, gold’s legacy as a reliable store of value spans centuries. Unlike digital currencies, gold is tangible and immune to hacking, technological failure and potentially becoming irrelevant as new technology is introduced. In times of financial uncertainty—such as during recessions, wars or political upheaval—gold has historically proven its resilience. Investors seeking more stability in their portfolios can look to gold to provide a hedge against the high volatility and ever-changing dynamics of cryptocurrencies.

For cryptocurrency investors who understand the importance of diversification, adding gold to their portfolios can be a smart move. Gold has a low correlation with cryptocurrency prices, meaning its value doesn’t necessarily move in tandem with Bitcoin or other digital assets. In times when the cryptocurrency market is experiencing significant price swings, gold can provide a stabilizing force while carrying many of the same advantages compared to other asset classes.

Why Gold May Be the Smartest Safe-Haven Asset

While cryptocurrencies may offer rapid growth opportunities, even the most trusted ones like Bitcoin are known to drop more than 75% after a bull cycle is over. Gold, on the other hand, has historically been a much less volatile asset. Its stability makes it especially attractive for long-term investors looking to mitigate risk. For crypto investors accustomed to the high-growth potential (and risk) of Bitcoin, gold’s lower volatility could serve as a reliable counterbalance.

Another key advantage of gold over digital currencies is its proven track record. Gold has survived economic upheavals, wars and inflationary periods—consistently maintaining its value. In contrast, Bitcoin and other cryptocurrencies have yet to be tested over multiple economic cycles, and while Bitcoin has shown resilience, it’s still in its relatively early stages as an asset class. This history gives gold a level of credibility and trust that Bitcoin, or any cryptocurrency, has yet to match.

Moreover, gold’s widespread acceptance and liquidity make it an ideal asset for investors looking for an easy-to-buy, easy-to-sell store of value. It’s recognized globally, and its markets are well-established, with ample infrastructure to support trading, storage and liquidation. For crypto investors accustomed to the ease and global reach of digital currencies, gold’s incredible liquidity and long-standing acceptance add a layer of dependability that’s hard to ignore.

McEwen Mining: A Hidden Gem in the Gold Sector

With the broader appeal of gold as an investment, let’s take a closer look at a company that is well-positioned to capitalize on the rising value of the precious metal—McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

McEwen Mining is an asset-rich diversified gold and silver producer in the Americas. The company also holds a 46.4% stake in McEwen Copper, which is developing the Los Azules copper project in Argentina—an important resource in its own right (https://ibn.fm/zgPFR). This combination of gold, silver and copper exposure presents a unique investment opportunity within the broader mining sector.

McEwen Mining’s financial performance in recent quarters demonstrates its potential. For instance, in Q3 2024, the company saw a 36% increase in revenue compared to the same period last year, driven by higher realized gold prices and increased production (https://ibn.fm/fwlmN). The average gold price sold by McEwen Mining in Q3 2024 was $2,499 per ounce, up from $1,920 per ounce in the previous year. This uptick in gold prices, improved operational efficiencies and higher production has had a significant impact on the company’s profitability, with gross profit increasing by a staggering 268% year-over-year to reach $13.8 million.

McEwen Mining is on track to meet its production guidance for 2024, and the company’s exploration and development efforts, including the acquisition of Timberline Resources, show strong promise for long-term growth. McEwen Mining has invested heavily in exploration, with a focus on extending the life of its mines and discovering new resource areas.

For crypto investors looking to diversify into gold, McEwen Mining presents a compelling opportunity. The company’s strong production numbers, focus on exploration and proven leadership makes it a promising choice for those seeking exposure to the gold sector. Moreover, McEwen Mining’s strategic exploration initiatives position it for long-term growth.

With analysts at Goldman Sachs and ING predicting gold could rise as high as $3,000 per troy ounce by the end of next year (https://ibn.fm/aFDqz), McEwen Mining stands to benefit significantly. As a relatively small-cap mining company with a growth-oriented strategy, McEwen Mining offers substantial upside potential. For crypto investors looking for a hedge against volatility and an attractive addition to their portfolios, McEwen Mining deserves a very close look.

For more information, visit the company’s website at www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

Top Player Lyncs: Elevating Your Golf Connection

In the world of golf, finding the right players to compete with or simply enjoy a friendly round with can make a huge difference. Recognizing this need, our GolfLync app has introduced the Top Player Lyncs feature, a powerful tool designed to bring golfers together based on skill level, interests and location. Here’s a closer look at how Top Player Lyncs is transforming the golfing community and helping golfers make meaningful connections.

What is Top Player Lyncs?

Top Player Lyncs is an exclusive feature within the GolfLync app that enables users to view and connect with their most compatible matches in their area. Whether you’re a beginner looking for a partner, or an experienced golfer seeking a challenge, Top Player Lyncs ensures you find the right people to match your needs. It’s all about creating stronger connections and making it easier than ever to build a local golfing network and improve your skills.

With this feature, you can easily:

  • Discover Top Players Nearby: Access a list of compatible players in your area, making it convenient to find individuals who match your skill level and preferences.
  • Connect Based on Common Interests: Top Player Lyncs personalizes the search by allowing you to connect with people who share similar interests, from casual games to serious practice rounds.
  • Build Your Golf Community: The feature is designed to help you cultivate a network of like-minded golfers, enabling long-term friendships and practice partnerships.

Real User Reviews:

GolfLync user “King Besr” said:

“I started using this app to grow my community of golfers. The first day l used the app connected with golfers right in my neighborhood. Love it!”

GolfLync user “Anthony” said:

“GolfLync to me has helped me build my golf community in Texas. I do enjoy the groups you can join, the opportunities to join golf groupings near you, and being able to see others enjoy the game by posting their enjoyment of the game. I hope GolfLync continues to grow and evolve so many more players can join and enjoy.”

How to Get Started

Using Top Player Lyncs is simple. Just update your GolfLync app to the latest version, and navigate to the Top Player Lyncs section. From there, you can set your preferences, browse top players in your area, and start connecting. We’re continuously enhancing this feature to provide a seamless experience, so stay tuned for even more exciting updates!

Join the Community Today

Don’t miss out on the opportunity to elevate your golfing experience with Top Player Lyncs. Start building your network, improve your game, and enjoy the sport like never before. The GolfLync app is here to help every golfer, at every level, find the right partners on the course.

Are you ready to meet your next golf partner? Download GolfLync and explore Top Player Lyncs today!

You can download the GolfLync app using the following text-anchored links:

For more information about GolfLync, visit GolfLync, download the app, and connect with community on FacebookX and LinkedIn.

As SportLync transitions from a niche golf networking app to a comprehensive sports social platform, the opportunities for growth and innovation are significant. The company is currently raising capital via a Regulation CF offering. To learn more or invest, click here.

For more information, visit the company’s website at www.SportLync.com.

NOTE TO INVESTORS: The latest news and updates relating to SportLync are available in the company’s newsroom at https://ibn.fm/SPORT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Brera Holdings PLC (NASDAQ: BREA) – A Company on a Mission to Deliver Social Impact Programs to Communities

  • Brera Holdings, an Ireland- and Italy-based, international holding company with a global portfolio of men’s and women’s sports clubs, remains committed to its mission to build shareholder value and deliver social impact programs through its teams
  • Its strategic investments have earned it a market cap of $10.04 million and an enterprise value of $9.21 million, with a presence across Europe, Asia and Africa
  • With a substantial revenue-generating opportunity in ticketing, media initiatives, digital content, live events, and merchandise sales, Brera Holdings continues to invest in both football and volleyball teams
  • So far, its efforts have earned it the 2024 Social Impact Through Soccer Award at IMPACT 5050

Brera Holdings (NASDAQ: BREA), a European-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach, is building shareholder value while also delivering social impact programs through its teams to their communities. Since its inception, the company has remained steadfast in building on the legacy brand of Brera F.C., efforts that have seen it spread beyond Europe to other continents.

According to Stock Analysis, today Brera Holdings has a market cap of $10.04 million and an enterprise value of $9.21 million (https://ibn.fm/1CXLW). This has been the product of strategic investment and a global sports portfolio that is growing and affirming the company’s ambition to become a global leader in its space. Among its significant achievements over the past few years, Brera Holdings ventured into the lucrative African market by establishing Brera Tchumene FC in Mozambique (https://ibn.fm/DyyaU).

In April 2023, the company strengthened its European presence with the acquisition of a 90% stake in Fudbalski Klub Akademija Pandev, a first-division football team in North Macedonia, ultimately providing it access to two major UEFA competitions and solidifying the company’s position in European football. Additionally, in June 2023, Brera made a strategic investment in Manchester United PLC, realizing a 74% gain. In September of the same year, the company ventured into the Asian market by acquiring Bayanzurkh Sporting Ilch FC in Mongolia. The club would later be rebranded as Brera Ilch FC, further bolstering Brera’s image and overall global footprint (https://ibn.fm/QMbs0). Most recently, Brera Holdings established a joint stock company for the North Macedonian women’s football club Tiverija Strumica, now known as Brera Tiverija FC, a wholly owned subsidiary of Brera Strumica FC, in June 2024. In September 2024, Brera announced plans to acquire an Italian Serie B club, having signed an exclusive letter of intent with a prospective club, and is proceeding with due diligence.

Brera Holdings’ sporting assets have not only focused on football, with the company pursuing a larger presence in the overall sporting space with a hand in various sports. This is evidenced by its majority ownership acquisition of UYBA Volley in 2023, an Italian Serie A1 women’s professional volleyball team (https://ibn.fm/oGcGb). These investments reflect the opportunity for multi-club ownership. More importantly, they highlight the company’s confidence in its market positioning.

“The growth of multi-club ownership and private equity is revolutionizing sports,” noted Pierre Galoppi, Brera Holdings’ CEO. “We believe that as more companies engage and provide resources, clubs can advance to more competitive leagues, increasing revenues and valuations. Rising valuations and uncorrelated returns are drawing attention from corporate investors, and we expect to see sports holding companies with diversified cash flows emerge as the landscape evolves,” he added (https://ibn.fm/nNWKy).

From a revenue generation standpoint, Brera Holdings looks to recoup its investments through ticketing, media initiatives, brand deals, digital content, live events, merchandise sales, and more. In October, the company partnered with THADDBOII, an influential figure in the digital content creation and social media sphere, for the creation and production of an original skit series, Brera F.C. Soccer Road to Glory (https://ibn.fm/K0hI4). This reflected the company’s digital strategy while highlighting its ambition and the lengths it is willing to go to grow its brand both on the ground and digitally.

Brera Holdings remains bullish about multi-club ownership and expects to stamp its position as a leader in this space, planning to grow its portfolio and expand its market reach, ultimately impacting individual communities worldwide. Its efforts have earned it the 2024 Social Impact Through Soccer Award at IMPACT 5050, with an eye on even more such awards as the organization progresses.

For company information, visit the company’s website at www.breraholdings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

Automation and Nightfood Holdings Inc. (NGTF): The Key to Survival in the Hospitality Industry

  • Automation solutions are transforming the $300 billion U.S. hospitality industry, from tasks to personalizing guest experiences
  • Nightfood Holdings, through its subsidiary Future Hospitality Ventures (“FHV”), is leading the charge in AI-powered hospitality solutions, aiming to enable hospitality operators to survive in a threatening environment
  • FHV is integrating AI and machine learning into the industry to streamline operations and deliver exceptional service, overcoming some of the industry’s top challenges

The hospitality industry is undergoing a radical transformation, forced upon it by the need to compete for survival. This revolution is driven by the rapid advancement of technological intelligence.

Many believe the benefits of AI are so profound, that only two types of hospitality operators will exist soon: Those that were early adopters, and those that are out of business.

One of the most significant applications of AI is its ability to automate routine tasks and improve efficiency. AI-powered bots can handle inquiries, freeing up staff to focus on more complex, human-like tasks. This technology can analyze vast amounts of data to identify trends and optimize pricing strategies, ultimately helping businesses from going under at such an early period.

Another key area where AI is making a difference is in personalization. By leveraging AI-powered CRM systems, businesses can gain a deeper understanding of their guests’ preferences and tailor their services accordingly. This can lead to increased customer satisfaction and loyalty, and ultimately long-term success. 

As this revolution plays out in real time, it’s crucial for these entrepreneurs to embrace AI technology before the industry moves on without them. By investing in AI-powered solutions, employers can stay competitive, improve efficiency in every region, and save their business.

The Evolving Landscape of Hospitality

The need to modernize has been fueled by labor shortages and rising costs plaguing the $300 billion U.S. hospitality industry. Nightfood Holdings (OTCQB: NGTF), through its subsidiary Future Hospitality Ventures (Future Hospitality), is pioneering Robots-as-a-Service (“RaaS”).

The hospitality industry is undergoing a tectonic shift. Future Hospitality is using automation to solve the labor crisis. The key is lowering barriers to entry for hospitality operators, allowing them to automate, survive and thrive.

Looking Ahead

Future Hospitality is actively collaborating with leading robotics providers to develop and deliver cutting-edge autonomous driven solutions. These collaborations are expected to yield industry-revolutionizing innovations that will forever alter the economic landscape of this industry.

Future Hospitality’s ambitious plans will focus initially on the popular Los Angeles area before expanding nationwide, bringing its novel solutions to hospitality venues across the country.

“The hospitality industry is at a technological crossroads where operators slow to adapt will be left behind,” said Sonny Wang, President of Future Hospitality. “We’ve seen similar patterns in other industries such as automotive, construction and real estate. This upheaval means tremendous opportunity for innovative solutions providers like Future Hospitality.”

When external forces and mega-trends force industry upheaval, windows of opportunity exist. The coming automation revolution is set to radically alter this $300 billion dollar industry.

For more information, visit the company’s website at NightfoodHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

Superior Group of Companies Inc. (NASDAQ: SGC) Featured in Coverage of NobleCon20

Established in 1920, Superior Group of Companies (NASDAQ: SGC) is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across healthcare apparel, branded products and contact centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. SGC is committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit the company’s website at www.superiorgroupofcompanies.com.

To view IBN’s virtual coverage of Noble’s 20th annual small and micro-cap investor conference, visit https://ibn.fm/NobleCon20

About IBN’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating at this year’s NobleCon. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Torr Metals Inc. (TSX.V: TMET) ‘Sets Stage’ for Major Discoveries with Exploration Efforts at Filion Gold Project

  • Discovering viable gold deposits involves advanced geoscientific techniques, significant financial investment and years of rigorous exploration and development.
  • Torr Metals, an emerging player in the mining sector, is making significant strides in gold exploration with its Filion project.
  • The company recently announced that it had organized field crews to undertake a large-scale surface exploration program at Filion.

Gold has long been a cornerstone of global economic stability, acting as both a store of value and a hedge against inflation. For centuries, this precious metal has provided a haven during economic downturns and geopolitical uncertainties. Central banks hold vast reserves of gold to underpin their currencies, and investors flock to it during times of market volatility. Despite gold’s central role in economic stability and as a haven, major new discoveries are rapidly decreasing due to a decades-long focus on previously drilled early-stage exploration projects that have yet to deliver just as existing deposits are declining in grade and productivity. With future gold resources shrinking, the need for fresh new discoveries has never been more urgent, highlighting the critical value of skilled leadership with a proven track record in exploration to identify new, economically viable deposits. Torr Metals (TSX.V: TMET), a mineral exploration company, is poised to deliver a potential new gold discovery adjacent to the Trans-Canada Highway 11 as it develops its northern Ontario-based 261 km2 Filion Gold Project (https://ibn.fm/J8Mlx).

Pioneering Exploration at Filion Backed by Proven Leadership

Amid this backdrop, Torr Metals is advancing exploration at its extensive 261 km² Filion Gold Project, aiming to unlock new greenfield gold potential. Encompassing an entire prospective greenstone belt and located conveniently along the Trans-Canada Highway, the Filion Project draws interesting parallels to the famed Hemlo gold deposit to the south, which was similarly situated before its landmark discovery and successive staking rush in the 1980s.

Torr Metals is taking a meticulous, strategic approach to its first year of exploration at the Filion Gold Project, employing phased exploration designed to maximize potential while mitigating risk. The company’s discovery of an undrilled 1.2-kilometer gold soil anomaly along the Trans-Canada Highway is particularly significant, given the rarity of finding such substantial undrilled mineralization, with high-grades up to 1.32 g/t gold, in a greenfield setting backed by substantial easy access to provincial and nearby mining infrastructure. This approach underscores Torr Metals’ commitment to discovery, marking a significant achievement by defining widespread gold mineralization in an area that others have overlooked.

Torr’s programs at Filion incorporates high-resolution geophysical surveys and geochemical sampling, laying a robust foundation for defining subsurface gold-bearing structures and guiding potential drill targeting. Most recently, the company announced that it had organized field crews to undertake a large-scale surface exploration program at Filion, including soil sampling and prospecting (https://ibn.fm/4pvYX). The extensive surface exploration is focused on 9 square kilometers of highly prospective and largely underexplored ground that could potentially expand on the initial 2024 soil anomalies while further delineating promising gold-bearing zones, setting the stage for a carefully planned maiden drill program that will be the first to drill these targets.

“We’re thrilled to mobilize field crews to the Filion Gold Project, where the untapped exploration potential is vast, spanning an unexplored 42 km structural corridor known for hosting high-grade gold,” said Malcolm Dorsey, president and CEO of Torr Metals. “Our 2024 program will focus on testing unexamined conductors, historical gold occurrences, and advancing the significant anomalies from 2023. Combined with new LiDAR data revealing untested outcrops and undrilled high-priority targets, this large-scale effort sets the stage for major grassroots discoveries in this highly prospective but underexplored region.”

Add to this an unmatched team of seasoned professionals, each bringing invaluable experience and a proven track record in the mining sector. Torr Metals is led by President and CEO Malcolm Dorsey, a dynamic exploration geologist with over a decade of success in advancing copper and gold projects from early-stages through to resource definition. Malcolm’s expertise and ability to generate projects through low staking costs greatly strengthened the company’s strategic vision and brought the Filion and Kolos projects into Torr’s portfolio with 100% ownership. Chairman John Williamson has raised nearly $1 billion in capital for exploration projects globally and played pivotal roles in discovering over 10 million ounces of gold across three continents. With 35 years in the industry, John has consistently driven ventures to TSX Venture 50(TM) recognition. Complementing them is Gordon Maxwell, a veteran geologist with nearly 40 years of global exploration management experience with Noranda, Xstrata and most recently Glencore, where he also served as business development manager. Together, this team combines extensive expertise, strategic foresight and relentless drive to propel Torr Metals toward success.

The Future of Gold Exploration with Torr Metals

Torr Metals exemplifies the determination and innovation required to tackle the challenges of modern gold exploration. The company’s efforts at Filion are setting the stage for a potentially significant gold discovery, which could bolster global supplies and provide economic benefits to the local community. As the world continues to rely on gold as a pillar of financial security, the work of companies such as Torr Metals is crucial.

In a highly competitive market where finding new gold resources is becoming increasingly difficult, Torr’s focus on exploring untapped, high-potential ground gives the company a unique edge. By uncovering mineralization in previously unexplored regions, Torr is in a prime position to unlock the next gold frontier in which it already holds a commanding land position, setting itself apart from competitors and positioning itself for potential success in an industry where new greenfield discoveries are becoming a necessity. As the Filion project progresses, it will be one to watch for both industry stakeholders and investors seeking exposure to the next wave of gold discoveries.

For more information, visit the company’s website at www.TorrMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to TMET are available in the company’s newsroom at https://ibn.fm/TMET

Social Media Strategies Summit Addresses Social Media Challenges Faced by Public Agencies and Government Marketing Professionals

The Social Media Strategies Summit for Public Agencies & Government Organizations will be held on December 10-12, 2024, as a virtual conference. Executives and professionals managing social media channels of their public and government agencies are invited to attend the event.

SMSS is a networking platform that focuses on a niche audience of decision-makers, influencers, marketers, and professionals from the social media spectrum. Digital marketing experts and professionals will share effective tips and time-tested strategies for engagement with a targeted audience.

The event will commence on December 10 with a pre-summit workshop that will be conducted by experts who will discuss all aspects of social media marketing. The summit will be held on December 11-12, 2024, with live streaming sessions, 30-minute talks and panels, along with a 15-minute Q & A session among the speakers and the audience.

Experts hosting the panels and speaker sessions will discuss several important topics that impact the agency’s social media outreach, including ways of overcoming barriers to make decisions based on the audience’s feedback, and how to run successful social media campaigns on tight budgets.

During the panel discussions, the audience can ask direct questions about particular challenges regarding social media marketing and learn ways to balance their professional and personal messaging. One of the sessions is dedicated to Canva, a versatile and user-friendly graphic design platform used for creating stunning visual content without requiring professional design knowledge.

Attendees will also learn insights into leveraging social media platforms to increase their organization’s reach, reputation and engagement with their target audience. They can share experiences and knowledge with peers attending the event. Respected professionals of the social media marketing realm will share actual case studies and discuss the most effective strategies to enable marketers to humanize their agency and build trust.

To learn more, please visit https://ibn.fm/W0qWo.

Annovis Bio Inc. (NYSE: ANVS) Concludes Q3 with Strategic Milestones and FDA-Cleared Phase 3 Program for Alzheimer’s Disease

  • Annovis provided business and financial updates for Q3 2024, spotlighting progress toward pivotal buntanetap trials in Alzheimer’s disease.
  • The FDA has cleared Annovis to proceed with a Phase 3 program, which will include a 6-month study to confirm buntanetap’s symptomatic benefits (beginning Q1 2025) and an 18-month study to explore potential disease-modifying effects.
  • Matthew Peterson, Ph.D., was appointed as Senior Clinical Scientist and will oversee quality and rigor in upcoming clinical trials.
  • Annovis filed three new patents for innovative combination therapies, involving buntanetap with Trulicity (dulaglutide), Viagra (sildenafil), and a combination of all three.
  • As of Nov. 8, 2024, the company reported a cash position of $13.6 million, providing sufficient runway to support all Phase 3 preparatory activities and to initiate the pivotal Phase 3 Alzheimer’s study in Q1 2025.

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), concluded the third quarter with significant milestones achieved and a clear path forward for its lead candidate, buntanetap.

Buntanetap is an innovative drug designed to target neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying, positioning buntanetap as a potential breakthrough in treating neurodegenerative diseases.

The drug candidate has been shown effective in improving the health of nerve cells and therefore cognition in AD and cognition and motor function in PD patients. Annovis recently completed a Phase 2/3 AD study, with encouraging results that were presented to the U.S. Food and Drug Administration (“FDA”) on Oct. 10, 2024. During that meeting, the FDA granted clearance to proceed with pivotal Phase 3 studies: a 6-month study aimed at confirming buntanetap’s symptomatic effects, set to begin in Q1 2025, and an 18-month study designed to demonstrate potential disease-modifying effects. The FDA also recognized buntanetap’s safety, raising no concerns regarding liver enzyme levels, drug interactions, dose selection, pharmacokinetics, population pharmacokinetics and confirmed that development could proceed using the new crystal form of buntanetap.

To ensure the successful completion of upcoming clinical trials, the company appointed Matthew Peterson, Ph.D., as Senior Clinical Scientist, who will be responsible for quality and rigor in the next studies.

“The third quarter was a milestone period that has clearly defined our path forward for buntanetap,” said Maria Maccecchini, Ph.D., Founder, President and CEO of Annovis. “With FDA approval to launch confirmatory Phase 3 studies in early AD, our team is focused on initiating a 6-month pivotal trial early next year. We also bolstered our IP portfolio with new patents for combination therapies involving buntanetap, reinforcing our commitment to finding innovative solutions for these debilitating conditions.”

The three new patents, filed on Sept. 30, 2024, cover combination therapies involving buntanetap with Trulicity (dulaglutide), Viagra (sildenafil), or a combination of all three, creating a multifaceted approach to treating neurodegenerative diseases.

During the third quarter, Annovis presented two posters at the 17th Clinical Trials on Alzheimer’s Disease (“CTAD”) conference in Madrid, showcasing buntanetap’s efficacy in Phase 2/3 AD study and the biomarker data.

In terms of Q3 financial results, the company announced that it has an adequate runway for all Phase 3 preparatory studies and for entering the pivotal Phase 3 AD study in Q1 2025, having cash and cash equivalents of $13.6 million as of Nov. 8, 2024.

For more information about the company, visit www.AnnovisBio.com, and social channels LinkedIn, X and YouTube.

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

13th Annual ROTH Technology Event Opens Doors to Investor Opportunities

The 13th Annual ROTH Technology Conference, hosted by investment bank Roth Capital Partners, is set to bring together innovative technology companies and investors on November 19-20, 2024, at the Hard Rock Hotel in New York City. This exclusive, by-invitation-only event will provide a focused platform for capital sources and entrepreneurs to connect, explore potential partnerships, and pursue financial growth opportunities in the technology industry.

Approximately 100 growth-oriented technology companies will be represented by their executive teams, with an additional dozen companies invited to participate. Attendees will engage in 40-minute, pre-arranged one-on-one and small-group meetings to discuss investment opportunities, capped by an evening networking social on the first day.

The event will showcase companies from key technology sectors, including software and enterprise applications, data analytics and AI, digital media, semiconductors, data infrastructure, intelligent systems, and IoT and wireless communication technologies. Confirmed attendees range across the industry spectrum, from A2Z Cust2Mate Solutions to Zeta Global Holdings Corp.

ROTH’s Managing Director and Chief Technical Strategist, JC O’Hara, will provide expert insights on technology’s role in the global market, drawing on his extensive research in analyzing asset performance and market trends.

Key Highlights:

  • Exclusive location in New York City, the global financial hub.
  • Two days of targeted, pre-qualified investor meetings with high-growth technology companies.
  • Expert market analysis from JC O’Hara, ROTH’s Chief Technical Strategist.
  • Networking opportunities through structured meetings and social gatherings.
  • Participation from approximately 100 leading technology companies.

For more information about this event and to request a registration opportunity, please visit https://ibn.fm/LxiQX

Kairos Pharma Ltd. (NYSE American: KAPA) Is ‘One to Watch’

  • Kairos Pharma’s partnership with Cedars-Sinai Medical Center enhances clinical trial efficiency and accelerates the development of new therapeutic solutions.
  • The company holds a robust intellectual property portfolio with patents extending through 2040, providing a strong competitive advantage in the oncology market.
  • ENV105, Kairos’s lead drug candidate, shows promise in reversing drug resistance in prostate and lung cancers, addressing key markets with high demand for novel treatments.
  • Positioned in high-growth oncology segments, Kairos Pharma meets substantial market needs, driven by the increasing global incidence of drug-resistant cancers.
  • The company’s focus on biomarker development improves patient targeting, enhancing therapy success rates and underscoring its commitment to precision medicine.

Kairos Pharma (NYSE American: KAPA) is a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics that target drug resistance and immune suppression, two significant barriers in effective cancer treatment. By addressing these mechanisms, Kairos aims to restore the efficacy of standard cancer treatments while enhancing the body’s natural immune responses against tumors.

The company’s mission is to develop a diverse portfolio of drug candidates to provide novel options for patients with limited treatment pathways. Kairos is advancing its therapeutic pipeline with a focus on partnerships, precision medicine and clinical trial efficiency, moving closer to delivering new solutions for durable cancer remissions and improved patient quality of life.

Headquartered in Los Angeles, California, Kairos Pharma combines research excellence with patient-centered care. Led by an accomplished team of scientists and executives, the company is committed to transforming the cancer treatment landscape through next-generation therapeutic solutions that meet the highest standards of efficacy and safety.

Development Pipeline

Kairos Pharma’s development pipeline features multiple candidates across clinical and preclinical stages, each targeting unique mechanisms of resistance to cancer treatment:

  • ENV105: Currently in a Phase 2 trial for castrate-resistant prostate cancer, ENV105 is administered in combination with Apalutamide to overcome anti-androgen resistance. The company recently dosed the first patient in this trial, marking an important milestone in advancing prostate cancer treatment. ENV105 is also in a Phase 1 trial for EGFR-driven non-small cell lung cancer, where it is combined with Osimertinib to address resistance in this hard-to-treat cancer type. Kairos’s partnership with PreCheck Health Services supports the confirmation of biomarkers to identify patients most likely to benefit from ENV105, enhancing precision in patient selection.
  • KROS201: This candidate has received IND clearance for glioblastoma and focuses on activating T cells outside the body to target and destroy tumor cells, specifically addressing aggressive and treatment-resistant cancers.
  • KROS101: Designed to increase the number and efficacy of T cells, KROS101 shows promise in enhancing the immune system’s response to cancer, complementing existing immunotherapies.
  • KROS102: Targeted at autoimmune diseases, KROS102 works by decreasing T cell activity, potentially offering a new approach to managing autoimmune conditions.
  • KROS301 and KROS401: These candidates focus on inhibiting cancer cell growth and mitigating immune suppression in advanced cancers, including triple-negative breast cancer.

Intellectual Property Portfolio

Kairos Pharma’s intellectual property portfolio secures exclusive rights to its advanced drug technologies and forms the backbone of its innovative approach in oncology. Key patents cover ENV105, protecting its mechanism of targeting CD105 to reverse resistance in prostate and lung cancers. This IP extends internationally and is valid until 2040, ensuring a secure competitive position in the cancer therapeutics market.

Additionally, Kairos’s portfolio includes patents for the KROS series (KROS101, KROS201, KROS301, and KROS401), covering applications in both cancer and autoimmune diseases. Many of these patents were developed through research at Cedars-Sinai Medical Center, from which Kairos holds exclusive, worldwide licensing rights. This robust IP framework positions the company to leverage its unique technologies across multiple therapeutic areas, with a clear focus on addressing unmet medical needs in cancer and immune-related conditions.

Market Opportunity

Kairos Pharma is positioned to address high-growth oncology markets that demand innovative solutions to overcome drug resistance. The prostate cancer market, estimated at $11.3 billion, and the EGFR-driven lung cancer market, valued at $14 billion, represent key segments where Kairos’s drug candidates, particularly ENV105, have significant potential. Rising cancer incidence globally further underscores the demand for effective treatments that can restore sensitivity to existing therapies.

The broader immunotherapy market, which is projected to reach up to $148 billion by 2030, represents another major growth area for Kairos Pharma. The company’s targeted approach aligns with the precision medicine trend in oncology, enabling the development of therapies tailored to patient needs. By addressing underserved areas in cancer treatment, Kairos is poised to meet substantial unmet needs in the oncology and immunotherapy markets.

Leadership Team

Dr. John S. Yu serves as CEO and Chairman of Kairos Pharma. An accomplished neurosurgeon and immunotherapy expert, Dr. Yu has developed numerous investigational drugs and led multiple clinical trials. He holds degrees from Stanford, Harvard Medical School and MIT, and his career is centered on groundbreaking research in cancer therapeutics.

Dr. Neil Bhowmick, Chief Scientific Officer, brings over 20 years of extensive biochemistry expertise, including filing and prosecuting patents for therapeutics and devices, authoring 110 peer-reviewed publications, and leading foundational and pre-clinical cancer research. He has successfully obtained regulatory approvals and conducted clinical trials. With more than 15 years of continuous NCI/NIH funding, Dr. Bhowmick’s work has been cited over 15,000 times. He holds six patents, including innovations in biomarker detection platforms and stromal-targeted therapeutics such as ENV 105 and ENV 205.

Dr. Ramchandran Murali, VP of Research and Development, is an immunologist and molecular engineer recognized for his work in developing pharmacological agents to counter immune suppression in cancer. His extensive research background is instrumental in advancing Kairos’s innovative drug pipeline.

Doug Samuelson, Chief Financial Officer, brings over 25 years of experience in finance, having served as CFO for various biopharma companies. His expertise in financial management and regulatory compliance provides strong support to Kairos Pharma’s strategic initiatives as a clinical-stage company.

For more information, visit the company’s website at KairosPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to KAPA are available in the company’s newsroom at https://ibn.fm/KAPA          

From Our Blog

ONAR Holding Corp. (ONAR) Takes the Lead in AI-Driven Marketing as CEO Shares Vision

June 13, 2025

ONAR Holding Corp. (OTCQB: ONAR) is staking its claim as a leader in AI-driven marketing, as CEO Claude Zdanow discusses the company’s powerful strategy to support middle-market firms through intelligent, data-focused innovation. In a recent Digital Journal interview, Zdanow detailed ONAR’s mission to deliver integrated, tech-first marketing solutions tailored to growth-stage enterprises (ibn.fm/9ysN6). Throughout the […]

Rotate your device 90° to view site.